Journal article
Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment
- Abstract:
- SummaryIn the randomised TARGIT-A trial, risk-adapted targeted intraoperative radiotherapy (TARGIT-IORT) during lumpectomy was non-inferior to whole-breast external beam radiotherapy, for local recurrence. In the long-term, no difference was found in any breast cancer outcome, whereas there were fewer deaths from non-breast-cancer causes. TARGIT-IORT should be included in pre-operative consultations with eligible patients.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 523.1KB, Terms of use)
-
- Publisher copy:
- 10.1038/s41416-020-01233-5
Authors
+ UCL Hospitals Charitable Foundation
More from this funder
- Funder identifier:
- 10.13039/100011088
- Grant:
- -
+ DH | NIHR | Health Technology Assessment Programme
More from this funder
- Funder identifier:
- 10.13039/501100000664
- Grant:
- HTA 07/60/49
- HTA 10/04/07
- HTA 14/49/13
- Publisher:
- Springer Nature [academic journals on nature.com]
- Journal:
- British Journal of Cancer More from this journal
- Volume:
- 124
- Issue:
- 9
- Pages:
- 1469-1474
- Publication date:
- 2021-02-02
- DOI:
- EISSN:
-
1532-1827
- ISSN:
-
0007-0920
- Language:
-
English
- Keywords:
- Pubs id:
-
1161442
- Local pid:
-
pubs:1161442
- Source identifiers:
-
W3127009987
- Deposit date:
-
2026-02-13
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2021
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record